Taylor Wessing advised Phagenesis on its financing round. Phagenesis, a medical device company founded in 2007 by Dr. Conor Mulrooney and Professor Shaheen Hamdy, has secured...
Phagenesis’ $42m Series D Financing Round
CUBE Global’s Strategic Growth Investment From Bregal Milestone
Taylor Wessing advised CUBE Global on the deal. The investment marks the first institutional capital investment for CUBE. Serving a number of the world’s largest financial...
Thought Machine’s $160 Million Series D Funding Round
Taylor Wessing advised Thought Machine on the deal. Thought Machine, the cloud native banking technology company, raised $160 million in its Series D funding round. The...
Argent Labs Ltd’s $40 Million Series B Fundraising
Taylor Wessing has advised Argent Labs Ltd on the deal. Argent Labs Ltd (‘Argent’) raised $40m in its Series B funding round to build a Web3 and...
Tyk’s $35 Million Growth Equity Funding Round
Taylor Wessing advised Tyk on the deal. The $35 million growth equity funding round was led by new investors Scottish Equity Partners (SEP), alongside existing investors MMC...
Beauty Pie’s USD$100 Million Series B Fundraising
Taylor Wessing advised Beauty Pie on the deal. Started over four years ago, Beauty Pie is now a recognised game changer, disrupting the traditional mark-ups on...
Yapily’s $51 Million Series B Funding Round
Taylor Wessing advised Yapily on the deal. The first closing was announced on 21 July 2021 (second closing subject to regulatory approvals), taking its total investment...